PRESIDENT AND COO · UNITED THERAPEUTICS Corp · Common Stock
Side
M
Value
$1.72M
Shares
14.6K
Price
$117.76
Executed
Jan 26, 2026
Disclosed
Jan 28, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 26 executedJan 28, 2026 disclosed
UTHR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+10 / 25
$1.7M reported value · new position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+1 / 15
Routine: 18 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Benkowitz Michael filed this Form 4 reporting a option exercise of UTHR on Jan 26, 2026. It became public on Jan 28, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
PRESIDENT AND COO
Benkowitz Michaelcik:0001673232
Issuer
UNITED THERAPEUTICS Corpcik:0001082554
Revision history · 0
No field has changed since this record was first ingested.
